The University of Warwick Library - WebBridge

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE) : survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
James, Nicholas D..  The Lancet.  v. 387. no. 10024.   2015-03-19. p. 1163 - 1177... issn: 0140-6736 .   

Online access not found

Sorry - based on the information provided, WebBridge cannot offer appropriate links.